1-(5-FLUOROPYRIMIDIN-2-YL)ETHANAMINE HCL, 95.0%, 250mg

4-Ethyl-3-iodobenzoic acid, 95.0%, 100mg

8-NITRO-1,4-DIOXASPIRO[4.5]DECANE, 95.0%, 10g

(5-(Benzyloxy)-2-fluorophenyl)boronic acid, 95.0%, 250mg

N,N-Diisopropylethylamine (DIPEA), 100mL, >=99.5%, for peptide synthesis, glass packaging

1-(2,2,2-TRIFLUOROETHYL)PIPERIDIN-4-ONE, 95.0%, 250mg

5-Chloro-4-methylbenzene-1,3-diamine, 98.0%, 100mg

4-Chloromethyl-benzoic acid tert-butyl ester, 95.0%, 1g

2-Chloro-4-(trifluoromethoxy)pyridine, 98%, 250mg

2-(6-Bromopyridin-2-yl)-2-methylpropanenitrile, 98%, 100mg

N-(5-bromo-2-methoxybenzyl)cyclopentanamine hydrobromide, 95.0%, 1g

4-Iodo-4'-nitrobiphenyl>98.0%(GC)5g

4-(4-Bromo-1H-pyrazol-1-yl)-1-methylpiperidine, 95%, 1g